Serentrix LLC
Serentrix LLC
Categories
Biotechnology
About
Serentrix is focused on developing novel therapies for pain to address opioid epidemic. Our Phase 2 ready compound is a novel molecule which has prior human exposure with a strong safety profile and proven MOAs relevant for neuropathic and IBS pain. Additional opportunity exists for the asset in Dry Eye, AMD, Uveal melanoma and Women's health.
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.